CDKN2A and cancer: HDIs, TSA, depsipeptide and sodium butyrate, were shown to enhance the expression of genes such as CDKN2A, CDKN1A, SALL3, RARb2, TERT and GATA4 in human cancer cell lines by active DNA demethylation of their respective promoters [39–41].